Absci Corporation

NASDAQ:ABSI

Biotechnology

Healthcare
$8.18 +1.04%

+$0.08 today

Market cap
$1.41B
Beta
2.46
P/E (TTM)
-9.4
EPS (TTM)
-$0.77
52W Low $2.24High $8.17

Volume 5.66M

Average 5.10M

ABSI Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Absci CorporationNASDAQ: ABSI

Total Equity · Q1 FY2026 · quarter ended Mar 2026

Total equity falls 13.5% from a year ago

Total equity stood at $171.97M at the end of Q1 FY2026, down 13.5% from a year earlier and down 9.2% from the prior quarter. Over 3 fiscal years it compounded at -11.6% a year.

Context

  • Total equity amounted to 87.9% of total assets at the end of Q1 FY2026, up 2.4 pp from a year earlier.
  • Total equity increased in 2 of the last 3 fiscal years.

What to watch

Whether total equity keeps falling in the next quarterly balance sheet after a -13.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$171.97M-9.2% QoQ
Last fiscal yearDec 2025
$189.45M+5.8% YoY
Year agoMar 2025
$198.8M-13.5% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-13.5%——
1 year+5.8%——
3-year CAGR-11.6%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
189.45M USD
Year-over-year change
+5.8%
4-year CAGR
-15.2%

Total Equity vs competitors

How ABSI compares with its peers on the latest reported figures

  • ABSI's Mar 2026 total equity of $171.97M is the lowest of the 3 companies compared; the peer median is $788.65M.
  • Its year-over-year change of -13.5% is the lowest of 2, against a peer median of +10.2%.
  • Total equity amounts to 87.9% of total assets for ABSI, versus a peer median of 76.6%.
ABSI Competitors Peer median
Total Equity for ABSI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ABCLAbCellera Biologics Inc.Sep 2026$1.06B +10.2%-7.8%70.8%
GENBGenerate Biomedicines, Inc.Mar 2026$514.8M ——82.3%
ABSIAbsci CorporationMar 2026$171.97M -13.5%-11.6%87.9%
Peer median (excluding ABSI) $788.65M+10.2%-7.8%76.6%

Competitors are the stored peer set for ABSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents252.57M59.96M72.36M41.21M20.03M
Short-term Investments0104.48M25.3M71.21M124.27M
Net Receivables1.43M1.55M2.19M00
Inventory10.51M15.02M000
Other Current Assets0020.73M21.41M5.28M
Total Current Assets273.08M186.86M120.58M133.83M149.57M
Property, Plant & Equipment (Net)58.65M58.04M45.82M33.14M23.77M
Goodwill21.34M21.34M000
Intangible Assets54.99M51.62M48.25M44.88M41.51M
Long-term Investments16.84M1.86M000
Tax Assets(16.84M)17.66M000
Other Non-current Assets18.14M(16.38M)2.65M1.76M1.44M
Total Non-current Assets153.12M134.15M96.72M79.78M66.72M
Total Assets426.2M321.01M217.3M213.61M216.3M
Account Payables8.39M2.41M1.5M3.53M2.76M
Short-term Debt2.4M2.95M3.26M2.73M873K
Tax Payables00000
Deferred Revenue1.35M445K3.17M1.12M739K
Other Current Liabilities0012.75M12.75M0
Total Current Liabilities33.86M30.27M29.56M28.66M22.77M
Long-term Debt1.12M7.98M4.66M1.26M0
Deferred Tax Liabilities743K238K186K00
Deferred Revenue (Non-current)00966K0436K
Other Non-current Liabilities12.16M35K109K133K1.02M
Total Non-current Liabilities26.23M16.32M11.56M5.82M4.08M
Total Liabilities60.09M46.59M41.12M34.48M26.85M
Common Stock9K9K9K12K15K
Retained Earnings(191.03M)(295.93M)(406.5M)(509.6M)(624.78M)
Accumulated OCI(13K)(120K)(37K)(4K)591K
Other Stockholders Equity00000
Minority Interest00000
Total Equity366.11M274.41M176.18M179.13M189.45M
Total Debt20.01M22.98M15.88M10.11M5.3M
Net Debt(232.56M)(36.97M)(56.48M)(31.11M)(14.72M)

Absci Corporation

NASDAQ:ABSI

Intrinsic Alpha fair value

Locked

Current Price

$8.18

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.